https://pubmed.ncbi.nlm.nih.gov/26799287/
Contribution of KRAS mutations and c.2369C T (p.T790M) EGFR to acquired resistance to EGFR-TKIs...
MUTKRAS could be an additional mechanism of escape from EGFR-TKI inhibition and cftDNA is a feasible approach to monitor the molecular development of drug...